Sabby Management’s BriaCell Therapeutics Warrant BCTXL Stock Holding History

Sabby Management’s Portfolio BCTXL Stock Details BCTXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$392K	Buy	+380,686	New	+$403K	6.87%	7

Other funds holding BCTXL

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Empery Asset Management New York $83M AUM

Heights Capital Management San Francisco, California $357M AUM 7.93% 1-Year Est. Return

MYDA Advisors Woodmere, New York $424M AUM 77.08% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Warberg Asset Management Winnetka, Illinois $343M AUM 23.37% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return